107 related articles for article (PubMed ID: 10344061)
1. A cost minimisation analysis of cardiac failure treatment in the UK using CIBIS trial data. Cardiac Insufficiency Bisoprolol Study.
Malek M; Cunningham-Davis J; Malek L; Paschen B; Tavakoli M; Zabihollah M; Davey P
Int J Clin Pract; 1999; 53(1):19-23. PubMed ID: 10344061
[TBL] [Abstract][Full Text] [Related]
2. [Bisprolol in heart failure: efficacy and costs in a French setting according to CIBIS II].
Lévy P; Mérot JL; Lechat P; Lévy E; Bogillot O
Therapie; 2001; 56(4):421-5. PubMed ID: 11677866
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of bisoprolol treatment for heart failure.
Di Stasi F; Scalone L; De Portu S; Menditto E; Mantovani LG
Ital Heart J; 2005 Dec; 6(12):950-5. PubMed ID: 16502708
[TBL] [Abstract][Full Text] [Related]
4. [Cost-effectiveness of bisoprolol in chronic heart failure].
Ekman M; Zethraeus N; Dahlström U; Höglund C
Lakartidningen; 2002 Feb; 99(7):646-50. PubMed ID: 11887711
[TBL] [Abstract][Full Text] [Related]
5. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
Fundam Clin Pharmacol; 1997; 11(2):138-42. PubMed ID: 9107560
[TBL] [Abstract][Full Text] [Related]
6. A cost-minimization of heart failure therapy with bisoprolol in the French setting: an analysis from CIBIS trial data. Cardiac Insufficiency Bisoprolol Study.
Levy P; Lechat P; Leizorovicz A; Levy E
Cardiovasc Drugs Ther; 1998 Jul; 12(3):301-5. PubMed ID: 9784910
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockade treatment in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) project. CIBIS Committees and Investigators. Cardiac Insufficiency Bisoprolol Study.
Lechat P
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S158-63. PubMed ID: 11534531
[TBL] [Abstract][Full Text] [Related]
8. Reduced costs with bisoprolol treatment for heart failure: an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II).
Eur Heart J; 2001 Jun; 22(12):1021-31. PubMed ID: 11428837
[TBL] [Abstract][Full Text] [Related]
9. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
[TBL] [Abstract][Full Text] [Related]
10. [Cost effectiveness of bisoprolol in heart failure. Economic evaluation of the Cardiac Insufficiency Bisoprolol Study (CIBIS) for Germany].
Schädlich PK; Paschen B; Brecht JG
Med Klin (Munich); 1997 Aug; 92(8):499-504. PubMed ID: 9340476
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of the Cardiac Insufficiency Bisoprolol Study for the Federal Republic of Germany.
Schädlich PK; Paschen B; Brecht JG
Pharmacoeconomics; 1998 Jan; 13(1 Pt 2):147-55. PubMed ID: 10176149
[TBL] [Abstract][Full Text] [Related]
12. Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial.
Castagno D; Jhund PS; McMurray JJ; Lewsey JD; Erdmann E; Zannad F; Remme WJ; Lopez-Sendon JL; Lechat P; Follath F; Höglund C; Mareev V; Sadowski Z; Seabra-Gomes RJ; Dargie HJ
Eur J Heart Fail; 2010 Jun; 12(6):607-16. PubMed ID: 20354032
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
Circulation; 1994 Oct; 90(4):1765-73. PubMed ID: 7923660
[TBL] [Abstract][Full Text] [Related]
15. [Practical advice on the treatment of cardiac insufficiency with beta-blockers. Announcement by the Italian Association of Hospital-based Cardiologists].
Tavazzi L
Rev Port Cardiol; 1999 May; 18(5):556-7. PubMed ID: 10475681
[No Abstract] [Full Text] [Related]
16. Bisoprolol: a review of its use in chronic heart failure.
McGavin JK; Keating GM
Drugs; 2002; 62(18):2677-96. PubMed ID: 12466013
[TBL] [Abstract][Full Text] [Related]
17. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.
Lancet; 1999 Jan; 353(9146):9-13. PubMed ID: 10023943
[TBL] [Abstract][Full Text] [Related]
18. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
Willenheimer R; van Veldhuisen DJ; Silke B; Erdmann E; Follath F; Krum H; Ponikowski P; Skene A; van de Ven L; Verkenne P; Lechat P;
Circulation; 2005 Oct; 112(16):2426-35. PubMed ID: 16143696
[TBL] [Abstract][Full Text] [Related]
19. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
[TBL] [Abstract][Full Text] [Related]
20. [Cost effectiveness of bisoprolol in treatment of heart failure in Germany. An analysis based on the CIBIS-II study].
Szucs TD; Schwenkglenks M; Paschen B; Follath F
Med Klin (Munich); 2000 Dec; 95(12):663-71. PubMed ID: 11198553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
